These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 15104272)

  • 41. Guidelines for the treatment of arterial insufficiency ulcers.
    Hopf HW; Ueno C; Aslam R; Burnand K; Fife C; Grant L; Holloway A; Iafrati MD; Mani R; Misare B; Rosen N; Shapshak D; Benjamin Slade J; West J; Barbul A
    Wound Repair Regen; 2006; 14(6):693-710. PubMed ID: 17199834
    [No Abstract]   [Full Text] [Related]  

  • 42. [Medical therapy in peripheral arterial occlusive disease].
    Périard D; Hayoz D; Mazzolai L
    Rev Med Suisse; 2009 Feb; 5(189):312-5. PubMed ID: 19271648
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Extracardiac vascular disease and effectiveness of sustained clopidogrel treatment.
    Mukherjee D; Topol EJ; Moliterno DJ; Brennan DM; Ziada K; Cho L; Steinhubl SR;
    Heart; 2006 Jan; 92(1):49-51. PubMed ID: 15845611
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antiplatelet therapy for vascular interventions.
    Comerota AJ; Thakur S
    Perspect Vasc Surg Endovasc Ther; 2008 Mar; 20(1):28-35. PubMed ID: 18388025
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of lower extremity arterial circulation and implications for nursing practice.
    Bonham PA; Kelechi T
    J Cardiovasc Nurs; 2008; 23(2):144-52. PubMed ID: 18382257
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High prevalence of peripheral arterial disease and low treatment rates in elderly primary care patients with diabetes.
    Lange S; Diehm C; Darius H; Haberl R; Allenberg JR; Pittrow D; Schuster A; von Stritzky B; Tepohl G; Trampisch HJ
    Exp Clin Endocrinol Diabetes; 2004 Nov; 112(10):566-73. PubMed ID: 15578331
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antiplatelet therapy after endovascular intervention: does combination therapy really work and what is the optimum duration of therapy?
    Milani RV
    Catheter Cardiovasc Interv; 2009 Jul; 74 Suppl 1():S7-S11. PubMed ID: 19213064
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Life-style modification in peripheral arterial disease.
    Khan S; Cleanthis M; Smout J; Flather M; Stansby G
    Eur J Vasc Endovasc Surg; 2005 Jan; 29(1):2-9. PubMed ID: 15570264
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Clopidogrel as basic therapy in high-risk stroke patients].
    Mattle HP
    Praxis (Bern 1994); 2004 Aug; 93(34):1364. PubMed ID: 15468694
    [No Abstract]   [Full Text] [Related]  

  • 50. The effect of clopidogrel, aspirin and both antiplatelet drugs on platelet function in patients with peripheral arterial disease.
    Jagroop IA; Matsagas MI; Geroulakos G; Mikhailidis DP
    Platelets; 2004 Mar; 15(2):117-25. PubMed ID: 15154604
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Treating chronic occlusive arterial disease].
    Rottman M; Koepchen J; Angelkort B
    MMW Fortschr Med; 2005 May; 147(18):30-3. PubMed ID: 15934585
    [TBL] [Abstract][Full Text] [Related]  

  • 52. "Is this an ischemic ulcer?" An approach to peripheral arterial disease for dermatologists.
    McMurtry MS
    J Cutan Med Surg; 2009; 13 Suppl 1():S12-6. PubMed ID: 19480744
    [No Abstract]   [Full Text] [Related]  

  • 53. Propionyl-L-carnitine in Leriche-Fontaine stage II peripheral arterial obstructive disease.
    Allegra C; Antignani PL; Schachter I; Koverech A; Messano M; Virmani A
    Ann Vasc Surg; 2008; 22(4):552-8. PubMed ID: 18502605
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clopidogrel versus aspirin for secondary prophylaxis of vascular events: a cost-effectiveness analysis.
    Schleinitz MD; Weiss JP; Owens DK
    Am J Med; 2004 Jun; 116(12):797-806. PubMed ID: 15178495
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Practice guideline--peripheral arterial occlusive disease. Drug Committee of the German Medical Association].
    Z Arztl Fortbild Qualitatssich; 1997 Jul; 91(4):385-7. PubMed ID: 9340210
    [No Abstract]   [Full Text] [Related]  

  • 56. [Emergency measures in acute arterial occlusion. Why there are still colleagues who do it incorrectly?].
    Heiss JM
    MMW Fortschr Med; 2006 Mar; 148(12):19. PubMed ID: 16626001
    [No Abstract]   [Full Text] [Related]  

  • 57. Prophylactic antiplatelet therapy in peripheral arterial disease.
    Verhaeghe R
    Drugs; 1991; 42 Suppl 5():51-7. PubMed ID: 1726216
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Endovascular treatment of peripheral vascular disease.
    Allaqaband S; Solis J; Kazemi S; Bajwa T; ;
    Curr Probl Cardiol; 2006 Nov; 31(11):711-60. PubMed ID: 17052478
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Elevated plasma fibrinogen and diabetes mellitus are associated with lower inhibition of platelet reactivity with clopidogrel.
    Ang L; Palakodeti V; Khalid A; Tsimikas S; Idrees Z; Tran P; Clopton P; Zafar N; Bromberg-Marin G; Keramati S; Mahmud E
    J Am Coll Cardiol; 2008 Sep; 52(13):1052-9. PubMed ID: 18848137
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of and management approaches for the high-risk patient.
    Bhatt DL
    Am J Cardiol; 2006 Dec; 98(12A):22Q-29Q. PubMed ID: 17169626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.